Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Dadras, O. SeyedAlinaghi, S. Karimi, A. Shojaei, A. Amiri, A. Mahdiabadi, S. Fakhfouri, A. Razi, A. Mojdeganlou, H. Mojdeganlou, P. Barzegary, A. Pashaei, Z. Afsahi, A. M. Shobeiri, P. Mehraeen, E.

COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review

  • Adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Drzymalla, E. Green, R. F. Knuth, M. Khoury, M. J. Dotson, W. D. Gundlapalli, A.

COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Thorakkattil, S. A. Abdulsalim, S. Karattuthodi, M. S. Unnikrishnan, M. K. Rashid, M. Thunga, G.

COVID‐19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press

  • All age groups
  • COVID-19
  • Acceptance
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zhang, X. Tang, L.

Cultural adaptation in HPV vaccine intervention among racial and ethical minority population: a systematic literature review

  • Americas
  • United States of America
  • All age groups
  • Parents/caregivers
  • Human papillomavirus (HPV)
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Chenchula, S. Karunakaran, P.

Current Evidence on Efficacy of COVID-19 Booster Dose Vaccination Against the Omicron Variant. A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Shafie'ei, M. Jamali, M. Akbari, Z. Sarvipour, N. Ahmadzade, M. Ahramiyanpour, N.

Cutaneous Adverse Reactions Following COVID-19 Vaccinations: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Qaderi, K. Golezar, M. H. Mardani, A. Mallah, M. A. Moradi, B. Kavoussi, H. Shamsabadi, A. Golezar, S.

Cutaneous adverse reactions of COVID-19 vaccines: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bellinato, F. Fratton, Z. Girolomoni, G. Gisondi, P.

Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2022 ∙ Nguyen, B. Lalama, M. J. Gamret, A. C. Elman, S. A.

Cutaneous symptoms of connective tissue diseases after COVID-19 vaccination: a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Crawshaw, Alison F. Farah, Yasmin Deal, Anna Rustage, Kieran Hayward, Sally E. Carter, Jessica Knights, Felicity Goldsmith, Lucy P. Campos-Matos, Ines Wurie, Fatima Majeed, Azeem Bedford, Helen Forster, Alice S. Hargreaves, Sally

Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review

  • Europe
  • All age groups
  • COVID-19
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
Loading...